My standard lipid panel looked really good. Total cholesterol 162, HDL 69, LDL 80, triglycerides 54. The kind of numbers that get a nod from your doctor and a "you're fine" and nothing else.
But I decided to look deeper. And what I found completely changed my care plan.
I am an occupational therapist, Certified Women's Health Specialist, and Certified Menopause Coach. I went through surgical menopause at 42. Cardiovascular health in midlife women is something I talk about with clients regularly. And still, when I dug deeper into my own numbers, I found something my standard panel had never indicated.
I am sharing this because I know how many women are sitting with a "normal" cholesterol panel, feeling reassured, and never being offered a more complete picture. If you are in perimenopause or menopause, this may be one of the most important things you read this year.
What a Standard Lipid Panel Does and Does Not Tell You
A standard lipid panel measures four things: total cholesterol, HDL (often called good cholesterol), LDL (often called bad cholesterol), and triglycerides. For most women, this is the only cardiovascular screening they receive at their annual visit. If the numbers fall within acceptable ranges, the conversation ends there.
But a standard lipid panel has significant limitations. It does not tell you how many cholesterol-carrying particles are actually circulating in your blood. It does not screen for genetically inherited lipoproteins that raise cardiovascular risk independently of everything else. And it tells you nothing about what is actually happening structurally inside your arteries.
It is a starting point. It is not the whole story.
ApoB: Why Particle Number Matters More Than Cholesterol Content
The first additional marker I asked my doctor to check was ApoB, or apolipoprotein B.
Here is the distinction that matters. LDL cholesterol measures the amount of cholesterol being carried in your blood. ApoB measures the actual number of particles carrying it. And particle number predicts cardiovascular risk more accurately than cholesterol content alone, particularly in midlife women.
It is possible to have a relatively low LDL number but a high number of small, dense particles transporting that cholesterol. Those small dense particles are more likely to penetrate arterial walls and contribute to plaque formation. ApoB captures that risk. A standard LDL measurement does not.
My ApoB came back at 68, which is quite good. But it was only part of the picture.
Lp(a): The Cardiovascular Risk Factor Most Women Have Never Heard Of
The second marker I checked was Lp(a), or lipoprotein little a. This is where things got more complicated.
My Lp(a) came back at 113. That is elevated.
Lp(a) is a lipoprotein similar in structure to LDL, but with an additional protein attached that makes it particularly atherogenic. It is genetically inherited. You are born with your Lp(a) level, and there is very little you can do to change it through lifestyle. Diet, exercise, and weight loss do not move it meaningfully. An elevated Lp(a) is not a reflection of how well you are taking care of yourself. It is simply your genetics.
What makes Lp(a) significant is that it is an independent cardiovascular risk factor. Even when everything else looks fine, elevated Lp(a) raises the risk of heart attack, stroke, and aortic valve disease on its own. It is associated with increased plaque formation and inflammation in arterial walls.
Most people have never had their Lp(a) checked. It is not part of a standard lipid panel. Your doctor may never have ordered it. You may be walking around with an elevated level and have no idea.
Why Cardiovascular Risk Increases During the Menopause Transition
Before I get to what happened next, I want to explain why this conversation is especially important for women in perimenopause and menopause.
For most of your reproductive years, estrogen was quietly protecting your cardiovascular system. It kept blood vessels flexible and responsive, supported healthy HDL cholesterol, helped regulate LDL and triglycerides, had anti-inflammatory effects on arterial walls, and helped maintain healthy blood pressure.
When estrogen declines during the menopause transition, all of that changes. Blood vessels become stiffer. LDL tends to rise. HDL may drop. Triglycerides can increase. Visceral fat, the metabolically active fat that accumulates around the organs, begins to build up even without changes to diet or exercise. Insulin resistance increases. Systemic inflammation increases.
None of this is a personal failure. It is the direct biological consequence of losing estrogen.
For women who went through early menopause, whether due to premature ovarian insufficiency or surgical menopause, the stakes are even higher. Losing estrogen before its natural time is itself an independent cardiovascular risk factor. I had surgical menopause at 42. That history, combined with my elevated Lp(a) and my family history of heart disease, is what led my doctor to order the next test.
What Is a Coronary Artery Calcium Scan and Who Should Consider One
A Coronary Artery Calcium scan, or CAC scan, is a low-dose CT scan of the heart that looks for calcified plaque in the coronary arteries. It takes approximately five minutes. It produces a score: zero means no calcified plaque detected, and any score above zero indicates some degree of calcification is present.
The CAC scan is significant because it is not a theoretical risk calculation. It does not estimate risk based on cholesterol numbers, age, or family history alone. It is a direct structural look at what is actually happening inside your arteries right now. It is one of the most powerful tools available for cardiovascular risk stratification, and it is widely underutilized, particularly in women.
Because of my elevated Lp(a), family history, and history of early surgical menopause, my doctor agreed I should have one.
My Insurance Denied the CAC Scan
Here is what happened next, and I am sharing it because it is part of the story and because it will likely happen to some of you.
My insurance denied the scan. The reason given was that it was considered preventive rather than diagnostic. So even with an elevated Lp(a), a documented family history of heart disease, and a history of early surgical menopause, the answer was no.
I paid $175 out of pocket. I am glad I could, because I know that for a lot of people $175 is not a number you simply absorb. That is groceries for the week. That is a utility bill. That is a decision between caring for yourself and caring for your family. No one should have to make that choice to access a five-minute preventive scan.
Our healthcare system does not pay for prevention. It pays for crisis. It pays for the heart attack, not the test that might have helped prevent it. That is not acceptable, and I want you to know going in that you may have to advocate for this test and potentially pay out of pocket. I hope you do not. But I want you to be prepared.
My CAC Scan Results and What Happened Next
My CAC scan showed mild plaque formation.
That result was not theoretical. It was not a risk factor on paper. There were already early signs of atherosclerosis present in my arteries. Something was already happening.
Because of that finding, I will be starting a statin. My doctor's target is to get my LDL below 70. This surprises some people, given that my LDL was already 80, which looks reasonable on a standard panel. But when plaque is already present, the treatment goal shifts. It is no longer about keeping cholesterol within a normal range. It is about being aggressive enough to slow or stop the progression of what is already there. Lower LDL targets, in the range of under 70 or even under 55 depending on the individual, are associated with reduced risk of plaque progression and cardiovascular events in people with evidence of existing atherosclerosis.
This was not a reaction to catastrophic numbers. It was a proactive clinical decision based on real structural evidence. That is exactly how prevention is supposed to work.
What to Ask Your Doctor: Cardiovascular Lab Testing in Perimenopause and Menopause
If you are in perimenopause or menopause and have not had a full cardiovascular conversation with your provider, here is what I would encourage you to ask about.
ApoB. Ask your doctor to include ApoB in your next lab order. It provides a more accurate picture of cardiovascular risk than LDL alone, particularly in midlife women, because it measures particle number rather than cholesterol content.
Lp(a). This needs to be tested at least once in every adult's life, and ideally earlier rather than later. It is genetically determined, does not respond to lifestyle changes, and is frequently elevated in women. Knowing your number matters because it informs how aggressively other risk factors should be managed.
CAC scan. If you have risk factors including a family history of heart disease, early or surgical menopause, elevated Lp(a), or a combination of factors, ask whether a CAC scan is appropriate for you. Be prepared to advocate for it, and be prepared that you may need to pay out of pocket.
Fasting glucose and insulin. These can be used to calculate HOMA-IR, a marker of insulin resistance. Insulin resistance increases during the menopause transition and is a significant and often overlooked driver of cardiovascular risk.
hsCRP. High-sensitivity C-reactive protein is a marker of systemic inflammation. Inflammation also increases during this transition and contributes to cardiovascular risk in ways that a lipid panel will not capture.
You do not have to wait for your provider to offer these tests. You can ask for them directly. And if your provider dismisses the question, that is useful information about whether this is the right provider for your midlife care.
Hormone Therapy and Cardiovascular Risk: What the Research Suggests
Hormone therapy is not FDA approved for the prevention of cardiovascular disease, and it is important to say that clearly. What the research does suggest is that women who initiate hormone therapy at menopause, or within ten years of their final menstrual period, appear to have a reduced risk of cardiovascular disease compared to those who do not. This is often referred to as the timing hypothesis or the window of opportunity. Starting hormones while arteries are still healthy and responsive appears to have protective effects that initiating therapy later does not replicate.
For women who experienced early or surgical menopause, the evidence is even more compelling. The loss of estrogen before its natural time is directly associated with increased cardiovascular risk, and for these women, hormone therapy is not simply about managing symptoms. It is a matter of long-term health protection. Unless there is a clear and documented contraindication, the evidence supports replacing what was lost.
If you had a surgical menopause or were told you were in early menopause and are not currently on hormone therapy, this is a conversation worth having with a provider who understands the nuance and the evidence.
Lifestyle Factors That Directly Affect Heart Health in Midlife
Alongside whatever clinical decisions you make, what you do every day has a meaningful impact on cardiovascular health during the menopause transition.
Prioritize protein, fiber, and a wide variety of whole plant foods. Aim for approximately 30 different plant sources per week, which includes vegetables, fruits, legumes, whole grains, nuts, seeds, herbs, and spices. This supports the gut microbiome in ways that have downstream effects on inflammation and metabolic health.
Minimize processed foods, added sugars, and alcohol. Alcohol has a more significant impact on cardiovascular risk in midlife than most women realize, and it tends to be underestimated in standard health conversations.
Aim for at least 150 minutes of movement per week and include resistance training. Building and maintaining muscle mass supports insulin sensitivity and metabolic health in ways that directly benefit cardiovascular function.
Protect your sleep. Seven to eight hours is not a luxury. Poor sleep raises blood pressure, drives insulin resistance, and contributes to systemic inflammation, all of which are significant cardiovascular risk factors.
Take chronic stress seriously. Sustained elevated cortisol is directly damaging to cardiovascular tissue. Managing stress is not a soft recommendation. It is a clinical one.
These are the same lifestyle pillars my coaching programs are built around. My clients are working on ways to implement these habits in sustainable ways that fit their real life, not an idealized version of it. And we gradually implement these changes, so they aren't overwhelming, and so they actually stick.
The Bottom Line on Women's Cardiovascular Health in Menopause
Heart disease is the leading cause of death among women. The menopause transition is one of the most significant and most underutilized opportunities to change that trajectory.
I caught something early because I knew what to ask for and had a provider who listened. A standard cholesterol panel that looked reassuring was not the end of the story. It was the beginning of a more complete one.
You deserve the same chance. Ask the questions. Request the tests. Advocate for the scan. Find a provider who takes your cardiovascular health seriously at this stage of life, not just the symptoms you can see.
If you want support figuring out what to bring to your provider, how to interpret your labs, or how to build a plan that accounts for where you are right now, that is the work I do with my clients. Learn more and book your Menopause Empowerment Session here.
Your health is worth the appointment, the conversation, and the follow-up.